Fear of cancer recurrence among Chinese cancer survivors: Prevalence and associations with metacognition and neuroticism
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Objective: Fear of cancer recurrence (FCR) represents a chronic burden for many cancer survivors. We determined FCR prevalence and potential correlates, specifically metacognitive styles and neuroticism among Chinese cancer survivors with breast or colorectal cancer. Methods: This study included 285 Chinese patients with breast (N = 173) and colorectal (N = 112) cancers at 8‐week postsurgery. Participants completed a set of baseline questionnaires evaluating FCR (Fear of Cancer Recurrence Inventory‐Short Form [FCRI‐SF]), metacognition (Metacognitions Questionnaire‐30), and neuroticism (Eysenck Personality Questionnaire). Scores of 13 to 21 were indicative of subclinical FCR on the FCRI‐SF. Scores greater than or equal to 22 indicated clinically significant levels of FCR. Fully adjusted multinomial logistic regressions identified correlates of subclinical and clinically significant FCR. Results: Respectively, 26.0% (n = 74) and 11.2% (n = 32) achieved scores indicating subclinical and clinically significant FCR. Expressing significantly more positive (OR = 1.21, P = .003) and negative (OR = 1.19, P = .005) beliefs about worry was associated with a higher likelihood of reporting subclinical FCR. Both higher neuroticism (OR = 1.28, P = .003) and more negative beliefs about worry (OR = 1.19, P = 0.035) were associated with an increased likelihood of experiencing clinically significant FCR. Conclusions: Positive and negative metacognitions may play an important role in the development of subclinical FCR. In particular, negative metacognition and neuroticism may elevate FCR from subclinical to a clinical level. The findings give insight into the identification of cancer survivors with subclinical or clinical FCR and aid the development of interventions aimed at changing metacognitive beliefs in order to manage FCR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Making sense of cronbach’s alpha.
Tavakol, M., & Dennick, R. (2011) · International Journal of Medical Education · doi:10.5116/ijme.4dfb.8dfd · Cited by 15,126
A revised version of the Psychoticism scale
Eysenck, S. B. G., Eysenck, H. J., & Barrett, P. (1985) · Personality and Individual Differences · doi:10.1016/0191-8869(85)90026-1 · Cited by 3,094
Leventhal, H., Diefenbach, M., & Leventhal, E. A. (1992) · Cognitive Therapy and Research · doi:10.1007/bf01173486 · Cited by 1,573 · cited 1×
“The Common Sense Model proposes that when confronting a health threat, cognitive and emotional processing systems are activated in parallel to motivate and guide responses as illness perceptions.(17,38) A health threat like cancer diagnosis usually evokes heightened emotional arousal that dominates cognitive content,…”
BackgroundFear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
Simard, S., Thewes, B., Humphris, G., Dixon, M., Hayden, C., Mireskandari, S., & Ozakinci, G. (2013) · Journal of Cancer Survivorship · doi:10.1007/s11764-013-0272-z · Cited by 1,217 · cited 7×
“We assessed physical symptom distress as previous studies report it is a strong correlate of FCR.(4,9)”
BackgroundMethodInfluentialSimard, S., & Savard, J. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-008-0444-y · Cited by 608 · cited 4×
“Scores of 13 to 21 were indicative of subclinical FCR on the FCRI‐SF. Scores greater than or equal to 22 indicated clinically significant levels of FCR. Fully adjusted multinomial logistic regressions identified correlates of subclinical and clinically significant FCR. Results: Respectively, 26.0% (n = 74) and 11.2% (…”
BackgroundInfluentialLebel, S., Ozakinci, G., Humphris, G., Mutsaers, B., Thewes, B., Prins, J., Dinkel, A., Butow, P., & on behalf of the University of Ottawa Fear of Cancer Recurrence Colloquium attendees (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3272-5 · Cited by 586
Koch, L., Jansen, L., Brenner, H., & Arndt, V. (2013) · Psycho-Oncology · doi:10.1002/pon.3022 · Cited by 511 · cited 1×
“Both cross‐ sectional and longitudinal studies of long‐term survivors report comparable prevalence of high FCR, highlighting its stability over the survivorship trajectory.(9,10) While this suggests that high FCR levels might represent a chronic burden for some cancer survivors, the extensive range involved may reflec…”
BackgroundFactors reported to influence fear of recurrence in cancer patients: a systematic review
Crist, J. V., & Grunfeld, E. A. (2013) · Psycho-Oncology · doi:10.1002/pon.3114 · Cited by 431
Screening and comorbidity of clinical levels of fear of cancer recurrence
Simard, S., & Savard, J. (2015) · Journal of Cancer Survivorship · doi:10.1007/s11764-015-0424-4 · Cited by 329
Simonelli, L. E., Siegel, S. D., & Duffy, N. M. (2017) · Psycho-Oncology · doi:10.1002/pon.4168 · Cited by 292 · cited 3×
“One potential mechanism involves maladaptive information processing styles.(2) The Self‐Regulatory Executive Function (S‐REF) model(17) suggests that maladaptive metacognition (beliefs about thinking) triggers cognitive attentional syndromes (CASs) embodying heightened self‐focused attention, rumination and worry, att…”
Background
Research works printed but not linked: 22
- 10.1093/jnci/djx030 · DOI · Paper page
- 10.1002/(SICI)1099-1611(199706)6:2<95::AID-PON250>3.0.CO;2-B · doi:10.1002/(sici)1099-1611(199706)6:2<95::aid-pon250>3.0.co;2-b
- 10.1002/pon.1481 · DOI · Paper page
- 10.1097/00002820-200603000-00007 · DOI · Paper page
- 10.1002/pon.4516 · DOI · Paper page
- 10.1007/s00520-018-4294-y · DOI · Paper page
- 10.1002/pon.3659 · DOI · Paper page
- 10.1002/pon.3252 · DOI · Paper page
- 10.1007/978-1-4613-2413-3 · DOI · Paper page
- 10.1002/pon.1153 · DOI · Paper page
- 10.1016/j.janxdis.2009.12.005 · DOI
- 10.1002/cncr.25740 · DOI · Paper page
- 10.1007/s11136-017-1585-6 · DOI
- 10.1016/j.ygyno.2011.11.029 · DOI
- Heron M, 2013, Deaths: leading causes for 2013, Natl Vital Statistics Syst, 65, 1
- Ngan RK, 2017, Overview of Hong Kong cancer statistics of 2015, Lung, 4, 1
- 10.1371/journal.pone.0107302 · DOI · Paper page
- 10.1016/j.jpainsymman.2007.12.008 · DOI
- 10.1002/sim.1388 · DOI
- Hayes A, 2018, Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression‐based Approach
- 10.3758/BRM.40.3.879 · DOI · Paper page
- 10.1002/pon.621 · DOI · Paper page
Cited by
Luigjes‐Huizer, Y. L., Tauber, N. M., Humphris, G., Kasparian, N. A., Lam, W. W. T., Lebel, S., Simard, S., Smith, A. B., Zachariae, R., Afiyanti, Y., et al. (2022) · Psycho-Oncology · doi:10.1002/pon.5921 · Cited by 332
Self-citationSpotlight on the Fear of Cancer Recurrence Inventory (FCRI)
Smith, A. B., Costa, D., Galica, J., Lebel, S., Tauber, N., van Helmondt, S. J., & Zachariae, R. (2020) · Psychology Research and Behavior Management · doi:10.2147/prbm.s231577 · Cited by 98
Wu, V. S., Smith, A. B., & Girgis, A. (2022) · European Journal of Cancer Care · doi:10.1111/ecc.13269 · Cited by 40
Peng, L., Yang, Y., Chen, M., Xu, C., Chen, Y., Liu, R., Cao, X., & Li, M. (2022) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2022.101686 · Cited by 39
Fong, T. C. T., & Ho, R. T. H. (2020) · Psycho-Oncology · doi:10.1002/pon.5363 · Cited by 30
Hosseini, S., Department of Health Psychology, F. O. P. A. E. S., Salehi, M., Department of Health Psychology, F. O. P. A. E. S., Jadidi, M., Department of Psychology, S. Q. B., Aghili, M., & Department of Radiation Oncology, C. R. I. (2023) · Iranian Journal of Breast Diseases · doi:10.30699/ijbd.16.2.4 · Cited by 5
Metadata
- Authors
- Ng, D. W. L., Kwong, A., Suen, D., Chan, M., Or, A., Ng, S. S., Foo, C. C., Fielding, B. F. S., & Lam, W. W. T.
- Venue
- Psycho-Oncology
- Publisher
- Wiley
- Published
- 2019-04-26
- Volume
- 28
- Issue
- 6
- Pages
- 1243-1251
- ISSN
- 1057-9249 (ISSN-L)
- 1099-1611
- OpenAlex
- W2933788334
- Cited by
- 49
- References
- 17
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.